Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 0.4200
0.00 (0.00%)
Jun 15, 2026, 2:11 PM EST
Medicenna Therapeutics Employees
Medicenna Therapeutics had 18 employees as of March 31, 2025. The number of employees increased by 2 or 12.50% compared to the previous year.
Employees
18
Change (1Y)
2
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-721.56K CAD
Market Cap
38.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 18 | 2 | 12.50% |
| Mar 31, 2024 | 16 | 0 | - |
| Mar 31, 2023 | 16 | -2 | -11.11% |
| Mar 31, 2022 | 18 | 5 | 38.46% |
| Mar 31, 2021 | 13 | 6 | 85.71% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Medicenna Therapeutics News
- 4 days ago - Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms - GlobeNewsWire
- 12 days ago - Medicenna's MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026 - GlobeNewsWire
- 18 days ago - Medicenna Therapeutics Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 18 days ago - Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs - GlobeNewsWire
- 24 days ago - Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet - GlobeNewsWire
- 4 weeks ago - Medicenna Announces the Launch of a Marketed Public Offering of Securities - GlobeNewsWire
- 4 weeks ago - Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma - GlobeNewsWire
- 6 weeks ago - Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 - GlobeNewsWire